Multidisciplinary Respiratory Medicine最新文献

筛选
英文 中文
Impact of bronchial thermoplasty on exacerbation rates, quality of life, and healthcare utilization in severe asthma: a systematic review and meta-analysis of long-term outcomes. 支气管热成形术对严重哮喘加重率、生活质量和医疗保健利用的影响:长期结局的系统回顾和荟萃分析
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-11-12 DOI: 10.5826/mrm.2026.1106
Abdulelah Alotaibi, Linah Alhassan, Amwaj Alshemmri, Abdullah Mastour Alotaibi, Yosof Essam Rihan, Abdulaziz Alassaf, Mohammad Saleh Dairi
{"title":"Impact of bronchial thermoplasty on exacerbation rates, quality of life, and healthcare utilization in severe asthma: a systematic review and meta-analysis of long-term outcomes.","authors":"Abdulelah Alotaibi, Linah Alhassan, Amwaj Alshemmri, Abdullah Mastour Alotaibi, Yosof Essam Rihan, Abdulaziz Alassaf, Mohammad Saleh Dairi","doi":"10.5826/mrm.2026.1106","DOIUrl":"https://doi.org/10.5826/mrm.2026.1106","url":null,"abstract":"<p><strong>Background: </strong>Bronchial thermoplasty (BT) utilizes regulated radiofrequency radiation to diminish airway smooth muscle and enhance asthma management. This study aimed to assess the long-term effects of BT on asthma exacerbation rates, quality of life, healthcare utilization, lung function, and safety in adults with severe asthma.</p><p><strong>Methods: </strong>We searched PubMed, Web of Science, and Scopus through August 2024. Seventeen studies (randomized controlled trials and observational cohorts) with ≥12-month follow-up were included. Outcomes assessed were exacerbations, quality of life, healthcare utilization, lung function, and adverse events. Data were synthesized using random-effects models.</p><p><strong>Results: </strong>BT was consistently associated with reductions in severe exacerbations and emergency visits. Improvements in asthma-related quality of life were observed and remained evident during long-term follow-up. In contrast, changes in lung function were modest and often not significant. Reported adverse events were generally mild, occurred mainly in the early weeks after the procedure, and no additional long-term safety concerns were identified.</p><p><strong>Conclusions: </strong>BT provides sustained clinical benefits in carefully selected severe asthma patients, improving quality of life and reducing exacerbations without long-term safety concerns.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1106"},"PeriodicalIF":2.1,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149396061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tirzepatide for the treatment of obstructive sleep apnea: from apnea-hypopnea index reduction to cardiometabolic risk mitigation-a narrative review. 替西帕肽治疗阻塞性睡眠呼吸暂停:从呼吸暂停低通气指数降低到心脏代谢风险缓解——一篇叙述性综述
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-11-04 DOI: 10.5826/mrm.2026.1137
Samrawit Mesfin-Bireda, Katherine Hillman Urek
{"title":"Tirzepatide for the treatment of obstructive sleep apnea: from apnea-hypopnea index reduction to cardiometabolic risk mitigation-a narrative review.","authors":"Samrawit Mesfin-Bireda, Katherine Hillman Urek","doi":"10.5826/mrm.2026.1137","DOIUrl":"https://doi.org/10.5826/mrm.2026.1137","url":null,"abstract":"<p><strong>Background: </strong>Obstructive sleep apnea (OSA) is a chronic respiratory disorder with nocturnal oxygen desaturation that is often associated with multisystemic sequelae such as hypertension, cardiovascular diseases, and increased morbidity and mortality. Obesity has been proposed as a modifiable risk factor; hence, the recent shift in focus to investigating anti-obesity medications for the management of OSA. Tirzepatide is the first U.S. FDA-approved pharmacotherapy for the treatment of moderate-to-severe OSA in adults with obesity to be utilized in combination with low caloric intake and physical activity, given its prior success in managing type 2 diabetes (T2D) and obesity.</p><p><strong>Methods: </strong>This narrative review evaluates tirzepatide and the SURMOUNT-OSA trial program as the key contemporary anchors for the pharmacological treatment of OSA in adults with concurrent obesity. Because the randomized evidence base currently comprises a single pivotal trial program, the review centers on SURMOUNT-OSA and its prespecified endpoints along with post hoc analyses, supplemented by observational, modeling, and mechanistic studies.</p><p><strong>Results: </strong>In the SURMOUNT-OSA program, tirzepatide produced randomized, placebo-controlled reductions in the apnea-hypopnea index, sleep apnea-specific hypoxic burden, body weight, and systemic inflammation. The program was designed around respiratory and metabolic endpoints rather than clinical events, so it cannot support conclusions about mortality, cardiovascular, or renal outcomes. Favorable signals for those events, including all-cause mortality, major adverse kidney events, and major adverse cardiovascular events, come only from nonrandomized observational cohorts and are best regarded as directional and exploratory rather than definitive.</p><p><strong>Conclusions: </strong> Tirzepatide may help frame OSA as a multifactorial and partially metabolically treatable disease and may represent a clinically meaningful expansion of treatment options alongside, rather than as a replacement for, established mechanical and procedural therapies. The available evidence is anchored in a single phase 3 trial program and limited by short follow-up and the absence of definitive comparative and long-term outcome data. Long-term durability of effect after discontinuation, generalizability beyond the SURMOUNT-OSA-eligible population, OSA-specific economic analysis, and head-to-head comparisons against CPAP remain the principal unsettled questions requiring dedicated long-term studies before firm clinical recommendations can be made.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1137"},"PeriodicalIF":2.1,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149327292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pathophysiological Concepts in Cardiovascular Medicine: Update 2026. 心血管医学病理生理学概念:更新2026。
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-11-03 DOI: 10.5826/mrm.2026.1143
Asad Ali Ahmed Cheema, Ayesha Ahmed Cheema, Eshal Muhammad, Ali Akbar Mithani
{"title":"Pathophysiological Concepts in Cardiovascular Medicine: Update 2026.","authors":"Asad Ali Ahmed Cheema, Ayesha Ahmed Cheema, Eshal Muhammad, Ali Akbar Mithani","doi":"10.5826/mrm.2026.1143","DOIUrl":"https://doi.org/10.5826/mrm.2026.1143","url":null,"abstract":"<p><p>Cardiovascular disease remains the leading cause of death worldwide, yet classification still relies largely on anatomy, hemodynamics, and function, which can group patients with different underlying disease biology. Human studies across cardiovascular conditions now identify vascular, myocardial, metabolic, renal, hematologic, and peripheral processes that modify disease expression beyond conventional labels. Atherogenic particle burden, lipoprotein(a), clonal hematopoiesis, myocardial energetic and genetic abnormalities, chamber remodeling, dysfunctional adiposity, iron deficiency, skeletal muscle dysfunction, and cancer-associated cardiac wasting illustrate how similar phenotypes can arise from different substrates. These observations are supported to varying degrees by genetic, longitudinal, imaging, physiological, tissue, and interventional evidence, and their relative importance differs across patients and disease stages. Association with disease severity or outcome should therefore not be interpreted automatically as causal or therapeutically modifiable. Longitudinal phenotyping can clarify temporal relationships, while mechanistic studies should establish target engagement and the expected biological or physiological response. Clinical outcome trials must then determine whether modifying a candidate pathway improves patient-relevant outcomes. Mechanistically informed phenotyping may complement established cardiovascular classification by refining patient selection, distinguishing clinically meaningful substrates from associated signals, and supporting mechanism-directed therapeutic development where the evidence is sufficiently robust, rather than replacing established clinical disease labels.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1143"},"PeriodicalIF":2.1,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149327291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigating the Real-Life Indoor Air Quality Impact of E-Cigarette Vaping. 调查电子烟对室内空气质量的实际影响。
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-11-02 DOI: 10.5826/mrm.2026.1117
Alessandro Borgini, Chiara Veronese, Cinzia De Marco, Andrea Tittarelli, Ario Alberto Ruprecht, Roberto Boffi
{"title":"Investigating the Real-Life Indoor Air Quality Impact of E-Cigarette Vaping.","authors":"Alessandro Borgini, Chiara Veronese, Cinzia De Marco, Andrea Tittarelli, Ario Alberto Ruprecht, Roberto Boffi","doi":"10.5826/mrm.2026.1117","DOIUrl":"https://doi.org/10.5826/mrm.2026.1117","url":null,"abstract":"<p><strong>Background: </strong>the widespread use of e-cigarettes (e-cigs) has raised significant public health concerns, particularly regarding the physical characteristics of the emitted aerosol. This pilot study addresses this gap by quantitatively assessing particulate matter (PM) emissions from e-cigs in a real-world indoor environment.</p><p><strong>Methods: </strong>using a portable optical particle counter (AirBeam3), we measured PM1, PM2.5, and PM10 concentrations during a round-trip walk along low- and heavy-traffic roads, and inside a bar with three individuals who were vaping.</p><p><strong>Results: </strong>results show that indoor e-cig use was associated with a marked increase in PM levels. The average PM2.5 concentration inside the bar with vapers was 28.8 µg/m³, with a peak of 84.7 µg/m³, which is 6.5 times higher than on a low-traffic street and 3.1 times higher than on a heavy-traffic street.</p><p><strong>Conclusions: </strong>we conclude that PM from e-cigs in indoor settings markedly deteriorates air quality. While this study cannot quantify direct health risks, these findings support precautionary considerations for extending indoor smoking bans to public places.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1117"},"PeriodicalIF":2.1,"publicationDate":"2026-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149327290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Chronic Obstructive Pulmonary Disease in the Era of Environmental Sustainability: Can We Achieve Excellence? 环境可持续性时代的慢性阻塞性肺疾病管理:我们能做到卓越吗?
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-10-28 DOI: 10.5826/mrm.2026.1092
Fabiano Di Marco, Federico Lavorini, Francesco Pistelli, Fabio Arpinelli, Claudio Micheletto, Pierachille Santus, Elisiana Carpagnano, Angelo Guido Corsico, Paola Rogliani, Maria D'Amato, Carmen Stabile, Federica Piccolo, Lorenzo Giovanni Mantovani
{"title":"Management of Chronic Obstructive Pulmonary Disease in the Era of Environmental Sustainability: Can We Achieve Excellence?","authors":"Fabiano Di Marco, Federico Lavorini, Francesco Pistelli, Fabio Arpinelli, Claudio Micheletto, Pierachille Santus, Elisiana Carpagnano, Angelo Guido Corsico, Paola Rogliani, Maria D'Amato, Carmen Stabile, Federica Piccolo, Lorenzo Giovanni Mantovani","doi":"10.5826/mrm.2026.1092","DOIUrl":"10.5826/mrm.2026.1092","url":null,"abstract":"<p><strong>Background: </strong>The healthcare sector is a major contributor to greenhouse gas emissions, prompting an urgent need for environmentally sustainable practices. Chronic Obstructive Pulmonary Disease (COPD) management presents unique challenges in this context due to the frequent use of metered-dose inhalers containing high global warming potential propellants and the resource-intensive nature of acute exacerbations.</p><p><strong>Methods: </strong>This expert consensus paper explores how COPD care can be optimized to reduce environmental impact, while maintaining high standards of clinical effectiveness. We examine the patient journey, adherence patterns, and therapeutic strategies, including the role of single-inhaler triple therapy in preventing exacerbation, as determinants of healthcare-related emissions.</p><p><strong>Results: </strong>The potential of dry powder inhalers, accurate diagnosis, patient engagement, and sustained disease stability are highlighted as levers for environmentally sustainable care. We advocate for the integration of environmental impact as a formal outcome in randomized controlled trials, supported by standardized Life Cycle Assessment methodologies.</p><p><strong>Conclusions: </strong>Our findings suggest that environmentally conscious COPD management is not only possible but may enhance clinical outcomes and system sustainability.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1092"},"PeriodicalIF":2.1,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149289753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tracking severe asthma improvement with biologic therapy using spirometry and impulse oscillometry: a real-world study. 使用肺活量测定法和脉冲振荡法追踪重度哮喘生物治疗的改善:一项真实世界的研究。
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-10-22 DOI: 10.5826/mrm.2026.1142
Alessandra Chiei Gallo, Laura Ventura, Lea Caron, Marta Guglieri, Eleonora Bono, Enrico Iemoli, Giovanna Elisiana Carpagnano, Andrea Portacci, Francesco Tursi, Valeria Ortolani
{"title":"Tracking severe asthma improvement with biologic therapy using spirometry and impulse oscillometry: a real-world study.","authors":"Alessandra Chiei Gallo, Laura Ventura, Lea Caron, Marta Guglieri, Eleonora Bono, Enrico Iemoli, Giovanna Elisiana Carpagnano, Andrea Portacci, Francesco Tursi, Valeria Ortolani","doi":"10.5826/mrm.2026.1142","DOIUrl":"10.5826/mrm.2026.1142","url":null,"abstract":"<p><strong>Background: </strong>Severe asthma patients receiving biologic therapy require accurate functional assessment and longitudinal monitoring. Spirometry and impulse oscillometry (IOS) may provide complementary information on lung function. The aim of this study was to compare spirometry and IOS in severe asthma patients treated with biologics, evaluating their concordance and clinical relevance, and to assess longitudinal changes in asthma control, oral corticosteroid (OCS) use, exacerbations, and healthcare utilization over 18 months.</p><p><strong>Methods: </strong>In this real-world dual-centre longitudinal study, 40 patients with severe asthma treated with biologic therapy underwent spirometry and IOS at baseline and after 6, 12, and 18 months. Functional findings were compared between the two techniques and correlated with asthma control, OCS use, exacerbations, hospitalizations, and healthcare utilization.</p><p><strong>Results: </strong>Significant clinical improvement was observed over 18 months, with reductions in exacerbations, hospitalizations, healthcare utilization and OCS use, alongside improved ACT scores. FEF25-75% showed partial functional improvement and significant correlations with IOS indices, particularly R5-R20 (r=-0.52 to -0.65) and AX (r=-0.30 to -0.54), supporting the complementary role of oscillometry in longitudinal assessment.</p><p><strong>Conclusions: </strong>Biologic therapy significantly reduced the clinical burden of severe asthma. IOS may provide complementary information alongside spirometry for longitudinal functional monitoring in real-life setting.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1142"},"PeriodicalIF":2.1,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722450/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247390","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Noninvasive ventilation in patients with amyotrophic lateral sclerosis: Is home sleep apnea testing a useful tool for initiating noninvasive ventilation? 肌萎缩性侧索硬化症患者的无创通气:家庭睡眠呼吸暂停测试是启动无创通气的有用工具吗?
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-09-16 DOI: 10.5826/mrm.2026.1088
Chiara Sanna, Mauro Sanna, Giuseppe Borghero, Stefania Redolfi
{"title":"Noninvasive ventilation in patients with amyotrophic lateral sclerosis: Is home sleep apnea testing a useful tool for initiating noninvasive ventilation?","authors":"Chiara Sanna, Mauro Sanna, Giuseppe Borghero, Stefania Redolfi","doi":"10.5826/mrm.2026.1088","DOIUrl":"10.5826/mrm.2026.1088","url":null,"abstract":"<p><strong>Introduction: </strong>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by motor neuron degeneration and eventual respiratory failure, often first manifesting during sleep. Timely detection of nocturnal respiratory impairment is critical for initiating noninvasive ventilation (NIV), one of the few therapies proven to improve survival. Although polysomnography (PSG) is the reference standard, it is not always readily available in clinical practice.</p><p><strong>Case presentation: </strong>We describe a 62-year-old man with spinal-onset ALS who underwent home sleep apnea testing (HSAT) for respiratory assessment. Although standard metrics were within normal limits, careful manual analysis of respiratory signals revealed diaphragmatic dysfunction through position-dependent desaturation and paradoxical breathing. NIV was initiated, resulting in improvements in sleep quality and daytime functioning.</p><p><strong>Conclusions: </strong>This case illustrates the value of HSAT as a pragmatic and accessible tool for early detection of respiratory involvement in ALS, particularly when combined with detailed waveform inspection in setting where PSG is unavailable. Additionally, it emphasizes the importance of individualized NIV titration and interface optimization to ensure adherence and therapeutic benefit.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1088"},"PeriodicalIF":2.1,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978671","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blood-based biomarkers associated with progressive pulmonary fibrosis in idiopathic inflammatory myositis-associated interstitial lung disease: A retrospective cohort study from a respiratory center. 与特发性炎性肌炎相关间质性肺病进行性肺纤维化相关的血液生物标志物:一项来自呼吸中心的回顾性队列研究
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-09-15 DOI: 10.5826/mrm.2026.1112
Mayuko Ishiwari, Yuta Kono, Kenichi Kobayashi, Ryota Kikuchi, Mariko Kogami, Takashi Okuma, Shinji Abe
{"title":"Blood-based biomarkers associated with progressive pulmonary fibrosis in idiopathic inflammatory myositis-associated interstitial lung disease: A retrospective cohort study from a respiratory center.","authors":"Mayuko Ishiwari, Yuta Kono, Kenichi Kobayashi, Ryota Kikuchi, Mariko Kogami, Takashi Okuma, Shinji Abe","doi":"10.5826/mrm.2026.1112","DOIUrl":"10.5826/mrm.2026.1112","url":null,"abstract":"<p><strong>Background: </strong>Interstitial lung disease (ILD) is a common extramuscular manifestation of idiopathic inflammatory myopathies (IIM). Progressive pulmonary fibrosis (PPF) can develop in a subset of patients with IIM-associated interstitial lung disease (IIM-ILD) and is associated with poor outcomes. This study aimed to evaluate the utility of blood-based biomarkers associated with PPF in patients with IIM-ILD.</p><p><strong>Methods: </strong>We retrospectively reviewed 54 consecutive patients diagnosed with IIM-ILD between January 2018 and December 2023. Patients were categorized as having PPF or not based on 2022 ATS/ERS/JRS/ALAT guideline criteria within 1 year after the diagnosis of IIM-ILD. Lung-specific macromolecules and systemic inflammatory and nutritional indices were calculated using laboratory data obtained at the initial evaluation. These included Krebs von den Lungen-6 (KL-6), surfactant protein-D, C-reactive protein-to-albumin ratio (CAR), neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), aggregate index of systemic inflammation (AISI), fibrosis-4 index, prognostic nutritional index, and geriatric nutritional risk index. Receiver operating characteristic curve analysis was used to determine optimal cutoff values, and logistic regression analyses were performed to identify factors associated with PPF.</p><p><strong>Results: </strong>Of the 54 patients, 32 were classified as having PPF and 22 as not having PPF. The PPF group showed significantly lower hemoglobin levels and significantly higher platelet counts, neutrophil counts, C-reactive protein, and serum KL-6 levels than the non-PPF group. Several systemic inflammatory indices, including CAR, NLR, MLR, PLR, SII, SIRI, and AISI, were significantly higher in the PPF group. AISI showed the highest discriminative ability among the evaluated biomarkers, with an area under the curve of 0.786 and an optimal cutoff value of 278. In multivariable logistic regression analysis, serum KL-6 ≥626 U/mL and AISI ≥278 were independently associated with PPF, with adjusted odds ratios of 6.480 (95% confidence interval [CI]: 1.440-29.200; p = 0.015) and 9.940 (95% CI: 2.260-43.600; p = 0.002), respectively.</p><p><strong>Conclusions: </strong>AISI and serum KL-6 may serve as accessible, non-invasive blood-based biomarkers associated with fibrotic progression in patients with IIM-ILD.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1112"},"PeriodicalIF":2.1,"publicationDate":"2026-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978728","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated B-lines quantification with lung ultrasound in mechanically ventilated patients. 机械通气患者肺超声自动b线定量分析。
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-09-10 DOI: 10.5826/mrm.2026.1069
Arianna Ciabattoni, Dejan Radovanovic, Tommaso Pozzi, Martina Gurgitano, Gianpaolo Carrafiello, Alessandro Monte, Silvia Coppola, Davide A Chiumello
{"title":"Automated B-lines quantification with lung ultrasound in mechanically ventilated patients.","authors":"Arianna Ciabattoni, Dejan Radovanovic, Tommaso Pozzi, Martina Gurgitano, Gianpaolo Carrafiello, Alessandro Monte, Silvia Coppola, Davide A Chiumello","doi":"10.5826/mrm.2026.1069","DOIUrl":"10.5826/mrm.2026.1069","url":null,"abstract":"<p><strong>Background: </strong>If ultrasound dedicated software for the identification and quantification of interstitial syndrome is equal or superior to experts observation is still being explored. The primary objective of this study was to compare the performance of an automatic method based on a dedicated software algorithm with that of expert clinicians in terms of B-lines quantification.</p><p><strong>Methods: </strong>Adult patients with acute respiratory failure who were deeply sedated, paralysed and mechanically ventilated were prospectively enrolled within 48 hours from ICU admission and underwent lung ultrasound by a trained physician. For each patient, 12 clips were stored, one for each thoracic region. The clips were then analyzed automatically using a built-in automatic recognition system and visually by two experts. A score of 0 was assigned if fewer than two B-lines were detected, a score of 1 if three or more B-lines were detected and a score of 2 if coalescent B-lines were detected.</p><p><strong>Results: </strong>A total of 40 patients were included in the study. Out of the 480 clips analysed, 54.2% had a lung score of 0, 6.8% had a lung score of 1, 8.8% had a lung score of 2 and 20.2% had a lung score of 3. The agreement between the experts in detecting the scores 0, 1, 2 was excellent (ICC = 0.82) in 383 (79.8%) clips. The agreement between the automatic system and the experts was poor (ICC = 0.33), with a significant difference (p < 0.001).</p><p><strong>Conclusions: </strong>In mechanically ventilated patients with acute respiratory failure, an automatic B-lines quantification system did not present an acceptable accuracy compared to expert consensus for B-lines counting, probably due to the coexistence of consolidation and pleural effusion.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1069"},"PeriodicalIF":2.1,"publicationDate":"2026-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148921853","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peri-procedural code status discussions before bronchoscopy: a cross-sectional survey of German and Swiss pulmonologists. 支气管镜检查前术中代码状态的讨论:德国和瑞士肺科医生的横断面调查。
IF 2.1
Multidisciplinary Respiratory Medicine Pub Date : 2026-09-03 DOI: 10.5826/mrm.2026.1098
Flavio Gössi, Armon Arpagaus, Benjamin Bissmann, Samuel Kaspar Zumbrunn, Thierry Girard, Jürgen Hetzel, Kathleen Jahn, Katrin E Hostettler, Sabina Hunziker
{"title":"Peri-procedural code status discussions before bronchoscopy: a cross-sectional survey of German and Swiss pulmonologists.","authors":"Flavio Gössi, Armon Arpagaus, Benjamin Bissmann, Samuel Kaspar Zumbrunn, Thierry Girard, Jürgen Hetzel, Kathleen Jahn, Katrin E Hostettler, Sabina Hunziker","doi":"10.5826/mrm.2026.1098","DOIUrl":"10.5826/mrm.2026.1098","url":null,"abstract":"<p><strong>Introduction: </strong>In-hospital cardiac arrest is associated with poor outcomes, yet peri-procedural code status discussions before bronchoscopy may be inconsistent, particularly in patients with elevated procedural risk.</p><p><strong>Methods: </strong>We conducted an anonymous online survey of a convenience sample of hospital-based pulmonologists in Germany and Switzerland between April and July 2025. The survey assessed routine practices and attitudes regarding peri-procedural code status discussions, risk stratification, and management of patients with pre-existing No-CPR status. Owing to distribution through multiple channels and secondary forwarding, a precise response rate could not be calculated.</p><p><strong>Results: </strong>A total of 148 pulmonologists participated (mean age 47.8 years; 94.6% board-certified). Discussions regarding CPR preferences were conducted almost always or most of the time before high-risk bronchoscopies by 67.6% of respondents, but were rarely or almost never performed before low-risk procedures by 72.0%. Respondents more frequently reported procedural risk than patient-related factors as a trigger for these discussions. Peri-procedural No-CPR status was considered controversial by 44.9%, and responsibility for these discussions varied among respondents. Only 25% reported formal institutional training.</p><p><strong>Conclusions: </strong>Substantial variability exists in peri-procedural code status practices before bronchoscopy. Clearer responsibilities and structured guidance are needed to better align care with patient preferences.</p>","PeriodicalId":51135,"journal":{"name":"Multidisciplinary Respiratory Medicine","volume":"21 ","pages":"1098"},"PeriodicalIF":2.1,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13722452/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148889252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书